Evidence map›Paper›PMID 25329386›Full record

Trial reportPloS one2014

Long term effectiveness on prescribing of two multifaceted educational interventions: results of two large scale randomized cluster trials.

Nicola Magrini, Giulio Formoso, Oreste Capelli, Emilio Maestri, Francesco Nonino, Barbara Paltrinieri, Cinzia Del Giovane, Claudio Voci, Lucia Magnano, Lisa Daya and 2 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 6 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 6 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Audit and feedback: effects on professional practice.The Cochrane database of systematic reviews · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Nicola MagriniDrug Evaluation Area, Emilia-Romagna Regional Agency for Health and Social Care, Bologna, Italy.
Giulio FormosoDrug Evaluation Area, Emilia-Romagna Regional Agency for Health and Social Care, Bologna, Italy.
Oreste CapelliLocal Health Authority, Modena, Italy.
Emilio MaestriDrug Evaluation Area, Emilia-Romagna Regional Agency for Health and Social Care, Bologna, Italy.
Francesco NoninoDrug Evaluation Area, Emilia-Romagna Regional Agency for Health and Social Care, Bologna, Italy.
Barbara PaltrinieriDrug Evaluation Area, Emilia-Romagna Regional Agency for Health and Social Care, Bologna, Italy.
Cinzia Del GiovaneDepartment of Clinical and Diagnostic Medicine and Public Health, University of Modena and Reggio Emilia, Modena, Italy.
Claudio VociDrug Evaluation Area, Emilia-Romagna Regional Agency for Health and Social Care, Bologna, Italy.
Lucia MagnanoDrug Evaluation Area, Emilia-Romagna Regional Agency for Health and Social Care, Bologna, Italy.
Lisa DayaLocal Health Authority, Modena, Italy.
Anna Maria MarataDrug Evaluation Area, Emilia-Romagna Regional Agency for Health and Social Care, Bologna, Italy.
INDRA-NET study group
Agenzia Sanitaria e Sociale Regionale · ITRegione Emilia-RomagnaAzienda Unita' Sanitaria Locale Di Modena · ITUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInformation on benefits and risks of drugs is a key element affecting doctors' prescribing decisions. Outreach visits promoting independent information have proved moderately effective in changing prescribing behaviours.

objectivesTesting the short and long-term effectiveness on general practitioners' prescribing of small groups meetings led by pharmacists.

methodsTwo cluster open randomised controlled trials (RCTs) were carried out in a large scale NHS setting. Ad hoc prepared evidence based material were used considering a therapeutic area approach--TEA, with information materials on osteoporosis or prostatic hyperplasia--and a single drug oriented approach--SIDRO, with information materials on me-too drugs of 2 different classes: barnidipine or prulifloxacin. In each study, all 115 Primary Care Groups in a Northern Italy area (2.2 million inhabitants, 1737 general practitioners) were randomised to educational small groups meetings, in which available evidence was provided together with drug utilization data and clinical scenarios. Main outcomes were changes in the six-months prescription of targeted drugs. Longer term results (24 and 48 months) were also evaluated.

resultsIn the TEA trial, one of the four primary outcomes showed a reduction (prescription of alfuzosin compared to tamsulosin and terazosin in benign prostatic hyperplasia: prescribing ratio -8.5%, p = 0.03). Another primary outcome (prescription of risedronate) showed a reduction at 24 and 48 months (-7.6%, p = 0.02; and -9,8%, p = 0.03), but not at six months (-5.1%, p = 0.36). In the SIDRO trial both primary outcomes showed a statistically significant reduction (prescription of barnidipine -9.8%, p = 0.02; prescription of prulifloxacin -11.1%, p = 0.04), which persisted or increased over time.

interpretationThese two cluster RCTs showed the large scale feasibility of a complex educational program in a NHS setting, and its potentially relevant long-term impact on prescribing habits, in particular when focusing on a single drug. National Health systems should invest in independent drug information programs.

trial registrationControlled-Trials.com ISRCTN05866587.

Indexed as

Drug Information ServicesDrug PrescriptionsGeneral PractitionersInterprofessional RelationsPharmacistsDrug Utilization ReviewHumansPractice Guidelines as Topic

Identifiers

PMID25329386
PMCPMC4201458
OpenAlexW2048390181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.